Results 201 to 210 of about 471,515 (268)

Anxiolytic and antidepressant effects of astaxanthin: behavioral and mechanistic insights in a rat model. [PDF]

Front Pharmacol
Ranjbari M, Fakhri S, Abbaszadeh F, Kiani A, Mohammadi-Noori E, Echeverría J.   +5 more
europepmc   +1 more source

Antihypertensive Regimens in Stabilized Hypertensive Patients at a Malagasy Tertiary Hospital. [PDF]

Cureus
Rakoto Sedson RO, Ranaivoson HMS, Miandrisoa RM, Nomenjanahary MH, Harioly Nirina MOJ, Rakotoarimanana S, Rabearivony N.   +6 more
europepmc   +1 more source

Towards a Safe Pathway to Biological Parenthood for Pulmonary Arterial Hypertension. [PDF]

Pulm Circ
Ingram JD, Nelson SM, Brewis MJ, Johnson MK, Church C.   +4 more
europepmc   +1 more source

The effects of glucagon-like peptide-1 receptor agonists on sympathetic neuron activity. [PDF]

Hypertens Res
Koyanagi Y, Iigaya K, Ikeda K, Onimaru H, Izumizaki M.   +4 more
europepmc   +1 more source

Prevalence of an endogenous LH rise following final GnRH antagonist dose in the IVF antagonist protocol. [PDF]

Eur J Obstet Gynecol Reprod Biol X
Løssl K, Wang NF, Bogstad JW, Dam TV, Bülow N, Bøtkjær JA, Petersen MR, Dessing LB, Oxlund-Mariegaard B, Celicanin MM, Pinborg A, Mamsen LS, Poulsen LC, Andersen CY.   +13 more
europepmc   +1 more source

Resting Cytosolic and Nuclear Reactive Oxygen Species (ROS) Are Regulated by the Basal Activity of ET-1 Receptors in Human Vascular Smooth Muscle Cells. [PDF]

Int J Mol Sci
Bkaily G, Semaan R, Jacques D.
europepmc   +1 more source

EXPRESSION OF CONCERN: A Newly Identified 45‐kDa JAK2 Variant with an Altered Kinase Domain Structure Represents a Novel Mode of JAK2 Kinase Inhibitor Resistance

Molecular Oncology, EarlyView.
wiley   +1 more source

Correction to “Differential activity of MEK and ERK inhibitors in BRAF inhibitor resistant melanoma”

Molecular Oncology, EarlyView.
wiley   +1 more source